Vanda Pharma Derivative Suit Will Stay In Delaware, On Ice

By Emilie Ruscoe (February 18, 2020, 9:26 PM EST) -- A Delaware federal judge on Tuesday told Vanda Pharmaceuticals Inc. that he would stay the derivative suit the company faces before him while at the same time shooting down Vanda's bid to move the case to a New York court where two similar lawsuits are playing out concerning the company's drug marketing practices....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!